Technological advancement and continuous research & development activities by the key companies such as Becton Dickinson Company, Novo Nordisk, YPSOMED HOLDING AG-REG, Medtronic, Tandem Diabetes Care, Sanofi, Biocon, Eli Lilly and Company, Insulet Corporation, Abbott, Roche, and others are providing the necessary momentum to the Insulin Delivery Devices Market growth.
However, the high cost associated with these technologically advanced devices and less awareness among patients are hampering the wide-scale adaptability.
Read more and know which MedTech player is leading the race in the Insulin Delivery Devices market:
Insulin Delivery Devices Market Size